tiprankstipranks
Trending News
More News >
Urogen Pharma (URGN)
NASDAQ:URGN
US Market

Urogen Pharma (URGN) Income Statement

Compare
652 Followers

Urogen Pharma Income Statement

Last quarter (Q3 2025), Urogen Pharma's total revenue was $27.48M, an increase of 9.04% from the same quarter last year. In Q3, Urogen Pharma's net income was $-33.35M. See Urogen Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 90.40M$ 82.71M$ 64.36M$ 48.04M$ 11.80M
Gross Profit
$ 81.52M$ 73.35M$ 56.70M$ 42.88M$ 10.79M
Operating Expenses
$ 178.30M$ 138.89M$ 135.74M$ 135.18M$ 137.53M
Depreciation and Amortization
$ 329.00K$ 1.71M$ 1.82M$ 831.00K$ 2.04M
EBITDA
$ -95.35M$ -60.35M$ -76.21M$ -91.46M$ -122.71M
Operating Income
$ -96.78M$ -65.54M$ -79.04M$ -92.29M$ -126.74M
Other Income/Expenses
$ -27.26M$ -32.79M$ -28.99M$ -17.08M$ 1.63M
Pretax Income
$ -124.04M$ -98.32M$ -108.03M$ -109.37M$ -125.11M
Net Income
$ -126.87M$ -102.24M$ -109.78M$ -110.82M$ -128.48M
Per Share Metrics
Basic EPS
$ -2.96$ -3.55$ -4.79$ -4.96$ -5.90
Diluted EPS
$ -2.96$ -3.55$ -4.79$ -4.96$ -5.90
Weighted Average Shares Outstanding
42.88M 28.83M 22.81M 22.35M 21.78M
Weighted Average Shares Outstanding (Diluted)
42.88M 28.83M 22.81M 22.35M 21.78M
Currency in USD

Urogen Pharma Earnings and Revenue History